Published in J Mol Biol on November 15, 1982
High efficiency polyoma DNA transfection of chloroquine treated cells. Nucleic Acids Res (1983) 9.94
Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. EMBO J (1986) 6.82
Polyomavirus enhancer contains multiple redundant sequence elements that activate both DNA replication and gene expression. Mol Cell Biol (1985) 3.91
Specific interaction of cellular factors with the B enhancer of polyoma virus. EMBO J (1985) 3.23
Polyomavirus origin for DNA replication comprises multiple genetic elements. J Virol (1983) 2.89
Replication origins and a sequence involved in coordinate induction of the immediate-early gene family are conserved in an intergenic region of herpes simplex virus. Nucleic Acids Res (1984) 2.35
Identification of Epstein-Barr nuclear antigen polypeptide in mouse and monkey cells after gene transfer with a cloned 2.9-kilobase-pair subfragment of the genome. Proc Natl Acad Sci U S A (1984) 2.32
Multiple binding sites for polyomavirus large T antigen within regulatory sequences of polyomavirus DNA. J Virol (1984) 2.25
Activation of the polyomavirus enhancer by a murine activator protein 1 (AP1) homolog and two contiguous proteins. Proc Natl Acad Sci U S A (1988) 2.24
The Epstein-Barr virus (EBV) early protein EB2 is a posttranscriptional activator expressed under the control of EBV transcription factors EB1 and R. J Virol (1989) 2.20
Species-specific in vitro synthesis of DNA containing the polyoma virus origin of replication. Proc Natl Acad Sci U S A (1986) 2.16
The Epstein-Barr virus (EBV) early promoter DR contains a cis-acting element responsive to the EBV transactivator EB1 and an enhancer with constitutive and inducible activities. J Virol (1989) 1.79
Bidirectional promoter elements of simian virus 40 are required for efficient replication of the viral DNA. Mol Cell Biol (1986) 1.79
Sequences in the polyomavirus DNA regulatory region involved in viral DNA replication and early gene expression. J Virol (1985) 1.60
Sequence and structural requirements of a herpes simplex viral DNA replication origin. Mol Cell Biol (1988) 1.55
Polyomavirus large T antigen binds independently to multiple, unique regions on the viral genome. J Virol (1983) 1.55
DNA replication origin of polyoma virus: early proximal boundary. J Virol (1983) 1.54
Common features of polyomavirus mutants selected on PCC4 embryonal carcinoma cells. EMBO J (1985) 1.51
Location of sequences in polyomavirus DNA that are required for early gene expression in vivo and in vitro. Mol Cell Biol (1984) 1.49
Nucleotides in the polyomavirus enhancer that control viral transcription and DNA replication. Mol Cell Biol (1987) 1.48
DNA binding activity of polyoma virus large tumor antigen. Proc Natl Acad Sci U S A (1984) 1.47
Nuclear activity from F9 embryonal carcinoma cells binding specifically to the enhancers of wild-type polyoma virus and PyEC mutant DNAs. Nucleic Acids Res (1986) 1.42
Inhibition of simian virus 40 DNA replication in CV-1 cells by an oligodeoxynucleotide covalently linked to an intercalating agent. Nucleic Acids Res (1990) 1.42
T-antigen expression by polyoma mutants with modified RNA splicing. EMBO J (1983) 1.39
Deletion analysis of the polyomavirus late promoter: evidence for both positive and negative elements in the absence of early proteins. J Virol (1989) 1.38
Guanine nucleotide contacts within viral DNA sequences bound by polyomavirus large T antigen. J Virol (1986) 1.37
Essential nucleotides in the polyomavirus origin region. J Virol (1984) 1.36
Multiple subelements within the polyomavirus enhancer function synergistically to activate DNA replication. Mol Cell Biol (1988) 1.33
Simian virus 40 and polyomavirus large tumor antigens have different requirements for high-affinity sequence-specific DNA binding. J Virol (1985) 1.31
Regulation of polyomavirus late promoter activity by viral early proteins. J Virol (1986) 1.26
cis-Acting components of human papillomavirus (HPV) DNA replication: linker substitution analysis of the HPV type 11 origin. J Virol (1995) 1.21
Polyomavirus late leader region serves an essential spacer function necessary for viability and late gene expression. J Virol (1986) 1.18
Sequence-dependent DNA replication in preimplantation mouse embryos. Mol Cell Biol (1985) 1.16
The polyomavirus enhancer comprises multiple functional elements. J Virol (1988) 1.14
DNA sequence requirements for replication of polyomavirus DNA in vivo and in vitro. Mol Cell Biol (1987) 1.14
Common regulatory elements control gene expression from polyoma early and late promoters in cells transformed by chimeric plasmids. Mol Cell Biol (1985) 1.12
The DNA-binding properties of polyomavirus large T antigen are altered by ATP and other nucleotides. J Virol (1991) 1.10
Replication-dependent transactivation of the polyomavirus late promoter. J Virol (1990) 1.10
Lymphoid and other tissue-specific phenotypes of polyomavirus enhancer recombinants: positive and negative combinational effects on enhancer specificity and activity. Mol Cell Biol (1986) 1.08
Immortalization of rat embryo fibroblasts by mutant polyomavirus large T antigens deficient in DNA binding. Mol Cell Biol (1986) 1.08
Activities of polyomavirus large-T-antigen proteins expressed by mutant genes. J Virol (1984) 1.04
The yeast GAL4 protein transactivates the polyomavirus origin of DNA replication in mouse cells. J Virol (1991) 1.03
Effects of position and orientation of the 72-base-pair-repeat transcriptional enhancer on replication from the simian virus 40 core origin. J Virol (1987) 1.02
Mutational analysis of polyomavirus small-T-antigen functions in productive infection and in transformation. J Virol (1989) 1.00
Requirements for species-specific papovavirus DNA replication. J Virol (1989) 0.99
Novel downstream elements upregulate transcription initiated from an Epstein-Barr virus latent promoter. EMBO J (1991) 0.98
Polyoma virus early-late switch: regulation of late RNA accumulation by DNA replication. Proc Natl Acad Sci U S A (1993) 0.98
Optimal replication of plasmids carrying polyomavirus origin regions requires two high-affinity binding sites for large T antigen. J Virol (1989) 0.96
New class of polyomavirus mutant that can persist as free copies in F9 embryonal carcinoma cells. Mol Cell Biol (1986) 0.93
Asp-286----Asn-286 in polyomavirus large T antigen relaxes the specificity of binding to the polyomavirus origin. J Virol (1989) 0.91
AP1 enhances polyomavirus DNA replication by promoting T-antigen-mediated unwinding of DNA. J Virol (1996) 0.91
Inhibition of polyoma DNA synthesis by base pair substitutions at the replication origin. Nucleic Acids Res (1984) 0.91
Mutationally altered ribonucleotide reductase from Escherichia coli: characterization of mutations isolated on multicopy plasmids. J Bacteriol (1984) 0.89
Altered susceptibility to tumor necrosis factor alpha-induced apoptosis of mouse cells expressing polyomavirus middle and small T antigens. J Virol (1997) 0.86
Unique requirement for the PyF441 mutation for polyomavirus infection of F9 embryonal carcinoma cells. J Virol (1988) 0.86
Replication from a proximal simian virus 40 origin is severely inhibited by multiple reiterations of the 72-base-pair repeat enhancer sequence. Mol Cell Biol (1988) 0.85
Replication and expression in mammalian cells of transfected DNA; description of an improved erythrocyte ghost fusion technique. Nucleic Acids Res (1983) 0.84
Murine polyomavirus and simian virus 40 large T antigens produce different structural alterations in viral origin DNA. J Virol (1995) 0.83
RNA processing in the polyoma virus life cycle. Front Biosci (Landmark Ed) (2009) 0.83
cis-acting sequences that control the level of viral DNA synthesis in the polyomavirus late region. J Virol (1989) 0.82
Functional role of the ultraviolet light responsive element (URE; TGACAACA) in the transcription and replication of polyoma DNA. Nucleic Acids Res (1992) 0.80
Polyomavirus large T antigen binds cooperatively to its multiple binding sites in the viral origin of DNA replication. J Virol (1998) 0.80
Selection of DNA clones with enhancer sequences. Proc Natl Acad Sci U S A (1994) 0.79
Glucocorticoids facilitate the stable transformation of embryonal rat fibroblasts by a polyomavirus large tumor antigen-deficient mutant. Proc Natl Acad Sci U S A (1988) 0.79
Intramolecular recombination in polyomavirus DNA is a nonconservative process directed from the viral intergenic region. J Virol (1994) 0.78
Persistence and tissue distribution of DNA in normal and immunodeficient mice inoculated with polyomavirus VP1 pseudocapsid complexes or polyomavirus. J Virol (2000) 0.76
Elements of the polyomavirus replication origin required for homologous recombination mediated by large T antigen. J Virol (1995) 0.75
High efficiency polyoma DNA transfection of chloroquine treated cells. Nucleic Acids Res (1983) 9.94
Replication of polyoma DNA in isolated nuclei. I. Characterization of the system from mouse fibroblast 3T6 cells. J Mol Biol (1972) 4.47
RNA-linked short DNA fragments during polyoma replication. Proc Natl Acad Sci U S A (1973) 4.42
Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats. Hum Mol Genet (2000) 3.17
Identification of an active disaccharide unit of a glycoconjugate receptor for pneumococci attaching to human pharyngeal epithelial cells. J Exp Med (1983) 2.80
Hydroxyurea-induced accumulation of short fragments during polyoma DNA replication. I. Characterization of fragments. J Virol (1973) 2.57
The PapG adhesin of uropathogenic Escherichia coli contains separate regions for receptor binding and for the incorporation into the pilus. Proc Natl Acad Sci U S A (1989) 2.36
Construction and analysis of viable deletion mutants of polyoma virus. J Virol (1979) 2.30
Hydroxyurea-induced accumulation of short fragments during polyoma DNA replication. II. Behavior during incubation of isolated nuclei. J Virol (1973) 2.27
Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia (2008) 2.15
Replication of polyoma DNA in isolated nuclei. II. Evidence for semi-conservative replication. J Mol Biol (1972) 2.10
Genetic analysis of non-insulin dependent diabetes mellitus in the GK rat. Nat Genet (1996) 1.96
Identification of binding sites on the regulatory A subunit of protein phosphatase 2A for the catalytic C subunit and for tumor antigens of simian virus 40 and polyomavirus. Mol Cell Biol (1992) 1.83
Sealing of gaps in duplex DNA by T4 DNA ligase. Nucleic Acids Res (1982) 1.81
Structural basis of the interaction of the pyelonephritic E. coli adhesin to its human kidney receptor. Cell (2001) 1.79
The role of proximity in the use of hospital emergency departments. Sociol Health Illn (1980) 1.67
Steroid diabetes--a sign of overtreatment with steroids in the renal graft recipient? Scand J Urol Nephrol Suppl (1980) 1.63
Characterization of polyoma mutants with altered middle and large T-antigens. J Virol (1981) 1.58
Hereditary papillary renal cell carcinoma: clinical studies in 10 families. J Urol (1995) 1.53
Lactose repressor-operator DNA interactions: kinetic analysis by a surface plasmon resonance biosensor. Anal Biochem (1993) 1.50
Ethidium-bromide-inhibited restriction endonucleases cleave one strand of circular DNA. Gene (1982) 1.49
[Physiopathology of mitochondria. From Luft's disease to aging and diabetes]. Lakartidningen (1993) 1.42
T-antigen expression by polyoma mutants with modified RNA splicing. EMBO J (1983) 1.39
Reversible renal failure during treatment with captopril. Br Med J (1979) 1.35
Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. J Clin Endocrinol Metab (1994) 1.30
Deletion mapping of a short polyoma virus middle T antigen segment important for transformation. J Virol (1983) 1.29
Synthesis of polyoma DNA by isolated nuclei. Biochem Biophys Res Commun (1971) 1.26
Serine protein kinase activity associated with rotavirus phosphoprotein NSP5. J Virol (1997) 1.22
Drainage of thoracic duct lymph in renal transplant patients. Transplantation (1976) 1.21
Glycopeptides bind MHC molecules and elicit specific T cell responses. J Immunol (1993) 1.18
Renal carcinoma (hypernephroma) occurring in 5 siblings. J Urol (1972) 1.16
High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase. J Clin Endocrinol Metab (1995) 1.14
Pathophysiological and genetic characterization of the major diabetes locus in GK rats. Diabetes (1999) 1.12
Inheritance of strabismus and the gain of using heredity to determine populations at risk of developing strabismus. Acta Ophthalmol Scand (1999) 1.12
Immunization with glycosylated Kb-binding peptides generates carbohydrate-specific, unrestricted cytotoxic T cells. Eur J Immunol (1996) 1.08
Identification of rat susceptibility loci for adjuvant-oil-induced arthritis. Proc Natl Acad Sci U S A (1998) 1.08
Multilevel regulation of low-density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in normal and leukemic cells. Blood (1994) 1.08
Frequency of emergency department attendances as a predictor of mortality: nine-year follow-up of a population-based cohort. J Public Health Med (1990) 1.08
Synthesis of spacer-arm, lipid, and ethyl glycosides of the trisaccharide portion [alpha-D-Gal-(1----4)-beta-D-Gal-(1----4)-beta-D-Glc] of the blood-group Pk antigen: preparation of neoglycoproteins. Carbohydr Res (1984) 1.08
Multiple free viral DNA copies in polyoma virus-transformed mouse cells surviving productive infection. J Virol (1977) 1.06
Enhancer effect of bovine papillomavirus E2 protein in replication of polyomavirus DNA. Nucleic Acids Res (1991) 1.05
Susceptibility loci for atopic dermatitis on chromosomes 3, 13, 15, 17 and 18 in a Swedish population. Hum Mol Genet (2002) 1.05
Activities of polyomavirus large-T-antigen proteins expressed by mutant genes. J Virol (1984) 1.04
A bovine rotavirus serotype 1: serologic characterization of the virus and nucleotide sequence determination of the structural glycoprotein VP7 gene. Virology (1992) 1.03
Comamonas denitrificans sp. nov., an efficient denitrifying bacterium isolated from activated sludge. Int J Syst Evol Microbiol (2001) 1.02
Analysis of rotavirus nonstructural protein NSP5 phosphorylation. J Virol (1998) 1.02
Steroid 21-hydroxylase deficiency: two additional mutations in salt-wasting disease and rapid screening of disease-causing mutations. Hum Mol Genet (1993) 1.02
Mutational analysis of polyomavirus small-T-antigen functions in productive infection and in transformation. J Virol (1989) 1.00
Amplification of the c-myc oncogene in human plasma-cell leukemia. Int J Cancer (1985) 0.99
Glycosylation with N-Troc-protected glycosyl donors. Carbohydr Res (1996) 0.98
The hospital emergency department as the primary source of medical care. Scand J Soc Med (1980) 0.98
Receptor analogues and anti-pili antibodies as inhibitors of bacterial attachment in vivo and in vitro. Ann N Y Acad Sci (1983) 0.97
Steroid 21-hydroxylase deficiency: three additional mutated alleles and establishment of phenotype-genotype relationships of common mutations. Proc Natl Acad Sci U S A (1992) 0.96
Viable polyoma virus variant with two origins of DNA replication. Virology (1982) 0.96
Phenotyping of individual pancreatic islets locates genetic defects in stimulus secretion coupling to Niddm1i within the major diabetes locus in GK rats. Diabetes (2001) 0.94
Two distinct binding sites for globotriaosyl ceramide on verotoxins: identification by molecular modelling and confirmation using deoxy analogues and a new glycolipid receptor for all verotoxins. Chem Biol (1996) 0.93
Conversion of p-methoxyphenyl glycosides into the corresponding glycosyl chlorides and bromides, and into thiophenyl glycosides. Carbohydr Res (1996) 0.93
DNA polymerase activities induced by polyoma virus infection of 3T3 mouse fibroblasts. J Virol (1976) 0.93
Replication of polyoma DNA accumlation of early replicative intermediates during hydroxyurea inhibition. Virology (1976) 0.93
Structural requirements for the glycolipid receptor of human uropathogenic Escherichia coli. Mol Microbiol (1995) 0.92
Structure at restriction endonuclease MboI cleavage sites protected by actinomycin D or distamycin A. FEBS Lett (1982) 0.92
Rats made congenic for Oia3 on chromosome 10 become susceptible to squalene-induced arthritis. Hum Mol Genet (2001) 0.92
Characterization of mutations on the rare duplicated C4/CYP21 haplotype in steroid 21-hydroxylase deficiency. Hum Genet (1994) 0.92
Characterization by phenotype of families with atopic dermatitis. Acta Derm Venereol (2000) 0.91
Inhibition of polyoma DNA synthesis by base pair substitutions at the replication origin. Nucleic Acids Res (1984) 0.91
Synergistic effect of partially inactivating mutations in steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab (1997) 0.91
Mapping of the c-myc, pvt-1 and immunoglobulin kappa genes in relation to the mouse plasmacytoma-associated variant (6;15) translocation breakpoint. EMBO J (1985) 0.91
Estimation of carbon-carbon bond lengths and medium-range internuclear distances by solid-state nuclear magnetic resonance. J Am Chem Soc (2001) 0.90
A new locus for autosomal recessive hypercholesterolemia maps to human chromosome 15q25-q26. Am J Hum Genet (2000) 0.90
Replication of polyoma DNA: effects of hydroxyurea and arabinosyl cytosine. Cold Spring Harb Symp Quant Biol (1975) 0.90
X-ray crystal structure of galabiose, O-alpha-D-galactopyranosyl-(1---4)-D-galactopyranose. Carbohydr Res (1986) 0.89
Phenotypic characterization of the Trp64Arg polymorphism in the beta 3-adrenergic receptor gene in normal weight and obese subjects. Diabetologia (1996) 0.89
Linkage analysis of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the rat identifies a locus controlling demyelination on chromosome 18. Hum Mol Genet (1999) 0.89
Oligosaccharide-receptor interaction of the Gal alpha 1-4Gal binding adhesin of Streptococcus suis. Combining site architecture and characterization of two variant adhesin specificities. J Biol Chem (1994) 0.89
Characterization of the chromosomal gene and promoter for human insulin-like growth factor binding protein-5. J Biol Chem (1994) 0.89
Lipid modulation of glycolipid receptor function. Availability of Gal(alpha 1-4)Gal disaccharide for verotoxin binding in natural and synthetic glycolipids. Eur J Biochem (1994) 0.89
Contiguous localization of the genes encoding human insulin-like growth factor binding proteins 1 (IGBP1) and 3 (IGBP3) on chromosome 7. Genomics (1992) 0.89
Impact of diabetic inheritance on glucose tolerance and insulin secretion in spontaneously diabetic GK-Wistar rats. Diabetes (1994) 0.89
Genetic stability of a porcine rotavirus RNA segment during repeated plaque isolation. Virology (1996) 0.88
The role of parathyroidectomy in the treatment of secondary hyperparathyroidism before and after renal transplantation. Scand J Urol Nephrol Suppl (1977) 0.88
Differences in the ratio of RNA encoding two isoforms of the insulin receptor between control and NIDDM patients. The RNA variant without Exon 11 predominates in both groups. Diabetes (1993) 0.88
Skeletal muscle contractile characteristics and fatigue resistance in patients with chronic heart failure. Eur Heart J (1996) 0.88
Haplotypes of the steroid 21-hydroxylase gene region encoding mild steroid 21-hydroxylase deficiency. Proc Natl Acad Sci U S A (1991) 0.88
The occurrence of congenital cataract in western Sweden. Acta Ophthalmol Scand (1999) 0.87
Increased mRNA levels of Mn-SOD and catalase in embryos of diabetic rats from a malformation-resistant strain. Diabetes (2000) 0.87
Genetic variation in the PTH pathway and bone phenotypes in elderly women: evaluation of PTH, PTHLH, PTHR1 and PTHR2 genes. Bone (2007) 0.87
Major histocompatibility complex class I binding glycopeptides for the estimation of 'empty' class I molecules. J Immunol Methods (1995) 0.87
Linkage and association to candidate regions in Swedish atopic dermatitis families. Hum Genet (2001) 0.86
Altered susceptibility to tumor necrosis factor alpha-induced apoptosis of mouse cells expressing polyomavirus middle and small T antigens. J Virol (1997) 0.86
Analysis of polyomavirus enhancer-effect on DNA replication and early gene expression. J Mol Biol (1991) 0.86
Steroid 21-hydroxylase (P450c21): a new allele and spread of mutations through the pseudogene. Hum Genet (1993) 0.86
Regulation of human insulin receptor RNA splicing in HepG2 cells: effects of glucocorticoid and low glucose concentration. Biochem Biophys Res Commun (1994) 0.86